Literature DB >> 30223089

Effect of narcotic prescription limiting legislation on opioid utilization following lumbar spine surgery.

Daniel B C Reid1, Kalpit N Shah2, Jack H Ruddell3, Benjamin H Shapiro3, Edward Akelman2, Alexander P Robertson2, Mark A Palumbo2, Alan H Daniels2.   

Abstract

BACKGROUND CONTEXT: Prescription opioid abuse is a public health emergency. Opioid prescriptions for spine patients account for a large proportion of use. Some states have implemented statutory limits on prescribers, however it remains unclear whether such laws are effective.
PURPOSE: This investigation compares opioid prescription patterns for patients undergoing lumbar spine surgery before and after the passage of statewide narcotic-limiting legislation in Rhode Island. STUDY DESIGN/
SETTING: Retrospective review of prospectively-collected medical and pharmacologic data. PATIENT SAMPLE: Two patient cohorts (pre-law January 1, 2016-June 31, 2016 and post-law June 1, 2017-December 31, 2017) that included all patients undergoing selected lumbar spine surgeries (lumbar discectomy, lumbar decompression without fusion, and posterior lumbar fusion).
METHODS: Demographic and surgical variables were collected from the patient's medical charts, and information on controlled substances was collected from the state prescription drug monitoring program database. Variables collected included the number of pills and total morphine milligram equivalents (MMEs) of the first prescription, number of prescriptions filled within 30 days of surgery, total MMEs filled in the 30-day postoperative period, and total MMEs filled from 30 to 90 days after surgery. For comparison of continuous variables, t test or Mann-Whitney U test were used as appropriate. Chi-squared analysis was utilized for comparison of categorical variables. Independent risk factors for prolonged postoperative opioid use were evaluated using logistic regression.
RESULTS: There were no significant differences between pre-law (n = 241) and post-law (n = 311) cohorts in terms of age, sex, preoperative opioid use, or preoperative anxiolytic use (p > .05). A greater than 50% decline was observed among all patients from the pre-law to the post-law period in terms of the number of pills (51.61 vs 23.60 pills, p < .001) and MMEs (525.56 vs 218.77 MMEs, p < .001) provided in the first postoperative opioid prescription. The mean total MMEs provided in the first 30 days decreased significantly (891.26 vs 628.63 MMEs, p < .001) despite an increase in the average number of opioid prescriptions filled (1.75 vs 2.04 prescriptions, p = .002) during this time. There was no significant difference in mean MMEs filled from 30 to 90 days. Upon subgroup analysis, there was a statistically significant decline in both the mean first prescription and total 30-day MMEs regardless of preoperative opioid status (all p < .05) or specific procedure performed (all p < .05). Preoperative opioid use was strongly associated with prolonged postoperative opioid requirements throughout the study period (OR 4.71, 95% CI 3.11-7.13, p < .001). There were no significant differences between cohorts in terms of emergency department (ED) visits or unplanned hospital readmissions at 30 and 90 days following surgery (all p > .05).
CONCLUSIONS: The institution of mandatory statewide opioid prescription limits has resulted in a significant reduction in initial and 30-day opioid prescriptions following lumbar spine surgery. Decreased opioid utilization was observed in all patients, regardless of preoperative opioid tolerance or procedure performed. No significant change in postoperative ED visits or unplanned hospital readmissions was seen following implementation of the legislation. This investigation provides preliminary evidence that narcotic limiting legislation may be effective in decreasing opioid prescriptions after lumbar spine surgery for both opioid-naïve and opioid-tolerant patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crisis; Law; Legislation; Lumbar; Opioid; Public health; Spine

Mesh:

Substances:

Year:  2018        PMID: 30223089     DOI: 10.1016/j.spinee.2018.09.007

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  16 in total

1.  Implementation and enforcement of state opioid prescribing laws.

Authors:  Elizabeth M Stone; Lainie Rutkow; Mark C Bicket; Colleen L Barry; G Caleb Alexander; Emma E McGinty
Journal:  Drug Alcohol Depend       Date:  2020-06-11       Impact factor: 4.492

Review 2.  American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients.

Authors:  Christopher L Wu; Adam B King; Timothy M Geiger; Michael C Grant; Michael P W Grocott; Ruchir Gupta; Jennifer M Hah; Timothy E Miller; Andrew D Shaw; Tong J Gan; Julie K M Thacker; Michael G Mythen; Matthew D McEvoy
Journal:  Anesth Analg       Date:  2019-08       Impact factor: 5.108

3.  Effects of state opioid prescribing cap laws on opioid prescribing after surgery.

Authors:  Ian Schmid; Elizabeth A Stuart; Alexander D McCourt; Kayla N Tormohlen; Elizabeth M Stone; Corey S Davis; Mark C Bicket; Emma E McGinty
Journal:  Health Serv Res       Date:  2022-07-29       Impact factor: 3.734

Review 4.  Evaluating opioid analgesic prescribing limits: A narrative review.

Authors:  Amy E Seitz; Karen A Janiszewski; Gery P Guy; Ryan T Tapscott; Emily B Einstein; Tamra E Meyer; Jessica Tierney; Judy Staffa; Christopher M Jones; Wilson M Compton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-03-17       Impact factor: 2.732

Review 5.  An Update on Postoperative Opioid Use and Alternative Pain Control Following Spine Surgery.

Authors:  Kevin Berardino; Austin H Carroll; Alicia Kaneb; Matthew D Civilette; William F Sherman; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2021-06-22

6.  Editor's Spotlight/Take 5: Has Prescription-limiting Legislation in Rhode Island Helped to Reduce Opioid Use After Total Joint Arthroplasty?

Authors:  Paul A Manner
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

7.  Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).

Authors:  Chris Delcher; Nathan Pauly; Patience Moyo
Journal:  Curr Opin Psychiatry       Date:  2020-07       Impact factor: 4.787

8.  State Opioid Limits and Volume of Opioid Prescriptions Received by Medicaid Patients.

Authors:  Hao Zhang; Srikar Tallavajhala; Shashi N Kapadia; Philip J Jeng; Yuyan Shi; Hefei Wen; Yuhua Bao
Journal:  Med Care       Date:  2020-12       Impact factor: 3.178

9.  Strategies aimed at preventing chronic opioid use in trauma and acute care surgery: a scoping review protocol.

Authors:  Mélanie Bérubé; Lynne Moore; François Lauzier; Caroline Côté; Kelly Vogt; Lorraine Tremblay; Marc-Olivier Martel; Gabrielle Pagé; Pier-Alexandre Tardif; Anne-Marie Pinard; S Morad Hameed; Kadija Perreault; Caroline Sirois; Carole Bélanger; Alexis F Turgeon
Journal:  BMJ Open       Date:  2020-04-14       Impact factor: 2.692

10.  Association of State Opioid Duration Limits With Postoperative Opioid Prescribing.

Authors:  Sunil Agarwal; John D Bryan; Hsou Mei Hu; Jay S Lee; Kao-Ping Chua; Rebecca L Haffajee; Chad M Brummett; Michael J Englesbe; Jennifer F Waljee
Journal:  JAMA Netw Open       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.